Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Alexandrakis

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Critical Reviews in Oncogenesis|April 2, 2018
Serum Levels of Soluble FLT3 Ligand in Patients with Active Multiple Myeloma Constitute Marker of Bone Marrow Plasma Cell Proliferative ActivityMaria Kokonozaki, Peggy Kanellou, Constantine A Pappa, et al.
Pathology, Research and Practice|October 28, 2008
Histological expression of angiogenic factors: VEGF, PDGFRalpha, and HIF-1alpha in Hodgkin lymphomaFreda H Passam, Michael G Alexandrakis, Maria Kafousi, et al.
Journal of Cancer Research and Clinical Oncology|March 17, 2015
Immunohistochemical expression of endoglin offers a reliable estimation of bone marrow neoangiogenesis in multiple myelomaMichael G Alexandrakis, Ioannis K Neonakis, Constantina A Pappa, et al.
Cytokine|September 24, 2011
Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myelomaC A Pappa, G Tsirakis, P Kanellou, et al.
European Journal of Gastroenterology & Hepatology|December 7, 2002
Acquired inhibitors to coagulation factors in patients with gastrointestinal diseasesDespina S Kyriakou, Michael G Alexandrakis, Freda H Passam, et al.
International Journal of Immunopathology and Pharmacology|May 13, 2005
Serum evaluation of angiogenic cytokine basic fibroblast growth factor, hepatocyte growth factor and TNF-alpha in patients with myelodysplastic syndromes: correlation with bone marrow microvascular densityM G Alexandrakis, F H Passam, C A Pappa, et al.
International Journal of STD & AIDS|June 1, 2012
Therapeutic combination of radiofrequency surgical dissection and oral acitretin in the management of perianal Buschke-Lowenstein tumour: a case reportP Mavrogianni, E Fallidas, E Nicolaidou, et al.
Chest|October 13, 2006
Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosisKaterina M Antoniou, Argyris Tzouvelekis, Michael G Alexandrakis, et al.
Hematological Oncology|September 16, 2011
Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myelomaGeorge Tsirakis, Constantina A Pappa, Peggy Kanellou, et al.
American Journal of Ophthalmology|March 8, 2000
Combined pars plana vitrectomy and glaucoma drainage implant placement for refractory glaucomaI U Scott, G Alexandrakis, H W Flynn, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Critical Reviews in Oncogenesis|April 2, 2018
Serum Levels of Soluble FLT3 Ligand in Patients with Active Multiple Myeloma Constitute Marker of Bone Marrow Plasma Cell Proliferative ActivityMaria Kokonozaki, Peggy Kanellou, Constantine A Pappa, et al.
Pathology, Research and Practice|October 28, 2008
Histological expression of angiogenic factors: VEGF, PDGFRalpha, and HIF-1alpha in Hodgkin lymphomaFreda H Passam, Michael G Alexandrakis, Maria Kafousi, et al.
Journal of Cancer Research and Clinical Oncology|March 17, 2015
Immunohistochemical expression of endoglin offers a reliable estimation of bone marrow neoangiogenesis in multiple myelomaMichael G Alexandrakis, Ioannis K Neonakis, Constantina A Pappa, et al.
Cytokine|September 24, 2011
Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myelomaC A Pappa, G Tsirakis, P Kanellou, et al.
European Journal of Gastroenterology & Hepatology|December 7, 2002
Acquired inhibitors to coagulation factors in patients with gastrointestinal diseasesDespina S Kyriakou, Michael G Alexandrakis, Freda H Passam, et al.
International Journal of Immunopathology and Pharmacology|May 13, 2005
Serum evaluation of angiogenic cytokine basic fibroblast growth factor, hepatocyte growth factor and TNF-alpha in patients with myelodysplastic syndromes: correlation with bone marrow microvascular densityM G Alexandrakis, F H Passam, C A Pappa, et al.
International Journal of STD & AIDS|June 1, 2012
Therapeutic combination of radiofrequency surgical dissection and oral acitretin in the management of perianal Buschke-Lowenstein tumour: a case reportP Mavrogianni, E Fallidas, E Nicolaidou, et al.
Chest|October 13, 2006
Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosisKaterina M Antoniou, Argyris Tzouvelekis, Michael G Alexandrakis, et al.
Hematological Oncology|September 16, 2011
Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myelomaGeorge Tsirakis, Constantina A Pappa, Peggy Kanellou, et al.
American Journal of Ophthalmology|March 8, 2000
Combined pars plana vitrectomy and glaucoma drainage implant placement for refractory glaucomaI U Scott, G Alexandrakis, H W Flynn, et al.
Pageof 15